Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Targeting the histone H3 lysine 79 methyltransferase DOT1L in MLL-rearranged leukemias ; volume:15 ; number:1 ; day:24 ; month:3 ; year:2022 ; pages:1-21 ; date:12.2022
Journal of hematology & oncology ; 15, Heft 1 (24.3.2022), 1-21, 12.2022
- Creator
-
Yi, Yan
Ge, Shenglei
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-022-01251-1
- URN
-
urn:nbn:de:101:1-2022061521231852276158
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:24 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Yi, Yan
- Ge, Shenglei
- SpringerLink (Online service)
Other Objects (12)
Using genome editing to model MLL rearranged leukemias
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The MLL recombinome of acute leukemias in 2013
Novel diagnostic and therapeutic options for KMT2A-rearranged acute leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
The molecular function of MLL/AF4 for patient derived acute leukemias growing in mice
Using genome editing to model MLL rearranged leukemias
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The MLL recombinome of acute leukemias in 2013
Novel diagnostic and therapeutic options for KMT2A-rearranged acute leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML
The molecular function of MLL/AF4 for patient derived acute leukemias growing in mice
Using genome editing to model MLL rearranged leukemias
Therapeutic strategies against hDOT1L as a potential drug target in MLL-rearranged leukemias
RNA binding proteins in MLL-rearranged leukemia
The MLL recombinome of acute leukemias in 2013
Novel diagnostic and therapeutic options for KMT2A-rearranged acute leukemias
Molecular pathogenesis of disease progression in MLL-rearranged AML
MLL rearrangements in pediatric acute lymphoblastic and myeloblastic leukemias: MLL specific and lineage specific signatures
Pharmacological inhibition of LSD1 for the treatment of MLL-rearranged leukemia
FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia
Functional diversity of inhibitors tackling the differentiation blockage of MLL-rearranged leukemia
SET-PP2A complex as a new therapeutic target in KMT2A (MLL) rearranged AML